background: This is the first study of the effect of epidermal growth factor (EGF) on marmoset monkey oocytes matured in vitro. methods: We have evaluated the effects of 10 ng/ml EGF in combination with 1 or 10 IU/ml of gonadotrophins (FSH/hCG 1:1 ratio) during in vitro maturation (IVM) of marmoset oocytes. Immature cumulus -oocyte complexes (COCs) were retrieved from ovarian antral follicles of unprimed monkeys. COCs from six animals (n ¼ 268) used in this study were randomly distributed among four experimental groups: (A) 1 FSH +1 hCG; (B) 10 FSH +10 hCG; (C) 1 FSH +1 hCG + EGF; and (D) 10 FSH +10 hCG + EGF (where 1 and 10 are concentrations, IU/ml). After IVM, oocytes were fertilized in vitro and embryos were allowed to progress up to 87-88 h.
Introduction
Marmoset monkey (Callithrix jacchus) is a non-endangered Brazilian primate species which is widely bred in captivity in the Northern Hemisphere. It is used in reproductive studies and as an important model for biomedical research. Marmosets belong to a genus which is multi-ovulatory, giving birth in captivity to two or more offspring twice a year.
The ovaries of C. jacchus have been studied only in captivity and under these conditions are active over the whole year. Between 20 and 150 antral follicles can be dissected per ovary pair (Gilchrist et al., 2001) . From these, a relatively large number of immature oocytes can be harvested without the necessity of exogenous hormonal stimulation. This is a major advantage over the mono-ovular macaque species, from which far fewer immature oocytes can be harvested from each animal (Schramm and Paprocki, 2000) without exogenous stimulation. This strategy additionally allows the study of requirements for in vitro maturation (IVM) of oocytes from a range of follicular stages, and provides a basis for investigating the consequences of suboptimal in vitro conditions. IVM of oocytes from non-FSH-primed marmosets has been reported to date only from our laboratory (Gilchrist et al., 1995 (Gilchrist et al., , 1997 Delimitreva et al., 2006) . There is one published study to date reporting successful fertilization and early embryo development to blastocyst stage from marmoset unstimulated IVM oocytes (Gilchrist et al., 1997) . However, these results have not been repeatable in studies in two laboratories, strongly suggesting that further optimization studies were necessary. The current basic protocol which was developed in our lab (Isachenko et al. abstract, 2000 and unpublished data) supports efficient rates of IVM, IVF and early embryo cleavage, and provides the essential basis for study of the effects of different factors. Further improvement of in vitro oocyte maturation for embryo production for marmoset is dependent on a critical investigation of components of the culture environment for their effects on the functional maturation of the oocyte.
The driving forces of follicle development and oocyte maturation are the gonadotrophins FSH and LH/CG. Optimization of the gonadotrophin concentrations for marmoset IVM was the main topic of investigation of Isachenko et al. (abstract, 2000 and unpublished data) . However, IVM is influenced not only by FSH and LH/CG but also the combinations and concentrations of local growth factors. Among the many growth factors which may be present in the in vivo follicular environment is epidermal growth factor (EGF), which has been shown to play an important role generally in the regulation of cell growth, proliferation and differentiation (Irwin et al., 1991; Ilio et al., 1995) . However, results investigating the action of EGF on oocyte maturation and developmental competence are variable, both in vitro (Das et al., 1991; Lonergan et al., 1996; Goud et al., 1998; Merlo et al., 2005) and in vivo (Martoriati et al., 2003) . Doses of EGF used in different studies vary greatly but 10 ng/ml EGF has usually produced optimal results in the dose-response studies and is therefore the most commonly used concentration for IVM for a range of different species (canine-Hatoya et al., 2009; mice-Das et al., 1991; pig-Abeydeera et al., 1998; bovine-Park et al., 1997) . Additionally, the effect and even the optimal dose of EGF might be expected to be influenced by the combination of other factors present, particularly the gonadotrophins (Harper and Brackett, 1993; Ding and Foxcroft, 1994) .
To our knowledge no study has been performed on any primate species concerning the effect of EGF on oocyte IVM, with the exception of Nyholt de Prada et al. (2009) who found no detectable effect of EGF in rhesus monkey at the dose used. Published results suggest significant species differences in response to EGF (Gó mez et al., 1993; Lonergan et al., 1996; Abeydeera et al., 1998; Ali and Sirard, 2002; Merlo et al., 2005; Bolamba et al., 2006) and different culture systems are used, therefore the results from other species cannot be applied directly to marmoset oocytes. Therefore, as part of the process of optimizing IVM and in vitro embryo development for marmoset, it is essential to investigate the effect of EGF directly on marmoset cumulus -oocyte complexes (COC) under the conditions of culture so far found to be optimal for this species. To acquire such information, in the present study, we have investigated the effects of EGF at a fixed dose of 10 ng/ml, in combination with two different gonadotrophin concentrations.
Materials and Methods

Animals
All procedures were carried out according to German Animal Experimentation Law (Animal Experiment Permission # 33.42502/08-01.03). Animals were housed according to standard German Primate Centre practice for this species (Gilchrist et al., 1997; Isachenko et al., 2002) . Seven female marmosets aged from 25 to 38 months (mean 31 months) and with body weight range from 327 to 475 g [mean 398 + 46 (SD) g] were used for the experiment. The females were housed with castrated partners and allowed to cycle naturally.
Material from six animals was used for statistical analysis in the present experiment as oocytes from one of the seven experimental animals failed to fertilize using sperm from a proven fertile male, and results from this animal were excluded from the study.
Cycle monitoring and control
Ovarian cycles were monitored by plasma progesterone levels (Heistermann et al., 1993) . The mean and variation in the length of follicular phase was calculated from several cycles prior to the beginning of an experiment and the operation was planned for 1 -3 days (depending on follicular phase length stability) before the most probable day of ovulation. Additionally, in order to make the day of the operation predictable, luteolysis was induced by i.m. injection of prostaglandin F 2a analogue (PGF-2a, Estrumate, Essex Tierarznei, Munich, Germany) on the cycle of the ovariectomy. The concentration of PGF-2a was 8 mg/ml and it was given between Day 10 and 15 of luteal phase in a dose adjusted according to animal weight: 0.15 ml (0.12 mg) PGF-2a per animal with the weight below 450 g, and 0.2 ml (0.16 mg) per animal above 450 g. The day after injection was counted as Day 1 of follicular phase.
Mean ovary volume was 0.15 + 0.04 cm 3 calculated as a product of height, width and length. Only follicles above 1000 mm in diameter were used for dissection. Between 32 and 68 COCs (mean 46 + 15) suitable for culture (based on the criteria given in Oocyte recovery and IVM) were recovered from 1 full + two-third ovaries. One-third of one ovary in the pair was always fixed for histology.
Media
Osmolarity of all media used was measured in a vapour pressure osmometer 'Vescor Vaprow 5520' (Kreienbaum Wissenschaftliche Meßsysteme, Langenfeld, Germany) and adjusted to 280 mOsm. One batch of fetal bovine serum (FBS, Biochrom AG, Berlin, Germany) was used throughout the whole experiment to eliminate potential background variability, although the EGF content was not known. For ovary collection, dissection and follicle puncture L-15 (Leibovitz medium, Sigma-Aldrich Chemie GmbH, Munich, Germany) supplemented with 10% v/v heat-inactivated FBS (Biochrom AG, Berlin, Germany), 1 mM GlutaMAX (Gibco-Invitrogen, Karlsruhe, Germany), 0.11 g/ml sodium pyruvate (Sigma-Aldrich), 0.03% w/v bovine serum albumin (BSA, Sigma-Aldrich), 5 IU/ml penicillin (Sigma-Aldrich) and 5 mg/ml streptomycin (Gibco-Invitrogen), pH 7.3 was used. The medium without hormones used for short-term storage of the oocytes was a-minimum essential medium (MEM, Gibco-Invitrogen) with 20% v/v heat-inactivated FBS, 1 mM GlutaMAX, 0.5 mM sodium pyruvate,10 mM sodium lactate (Sigma-Aldrich), 50 mg/ml L-ascorbic acid (Sigma-Aldrich), 5 IU/ml penicillin and 5 mg/ml streptomycin. For IVM this storage medium was additionally supplemented with 1 mg/ml b-estradiol (E 2 , Sigma-Aldrich) diluted in 98% v/v Ethanol (Carl Roth, Karlsruhe, Germany), gonadotrophic hormones (1 or 10 IU/ml) recombinant human FSH (Gonal-F; Serono Pharma, Zug, Switzerland) and 1 or 10 IU/ml hCG (Organon, Essex Pharma GmbH, Munich, Germany) and 10 ng/ml recombinant human EGF (Sigma-Aldrich) in the EGF positive experimental groups.
Hepes-buffered Tyrodes-lactate medium prepared in the lab (modification of Bavister and Yanagimachi, 1977; Gilchrist et al., 1997; ) was supplemented with 0.25 mM sodium pyruvate and 0.3% w/v BSA (pH 7.3) and used for collection, transportation and preparation of ejaculate (Isachenko et al., unpublished data For in vitro culture of embryos CMRL-1066 medium (Gibco-Invitrogen, 10 × aliquots without NaHCO 3 ) was used. Aliquots were kept at 2808C and thawed directly before culture medium preparation, as follows: 10 × aliquots of CMRL-1066 were diluted 1:10 and supplemented with 0.0022 g/1 ml NaHCO 3 (Sigma-Aldrich), 10% heat-inactivated FBS, 0.5 mM sodium pyruvate, 10 mM sodium lactate, 1 mM GlutaMAX, 1 IU/ml penicillin and 1 mg/ml streptomycin (modification of the rhesus embryo medium published by Zheng et al., 2003) .
Oocyte recovery and IVM
Ovariectomy was performed on anaesthetized animals using standard procedures of German Primate Centre. The animals were either used later as sterile partners for sperm donors or euthanized and their organs were used for other studies (results reported separately). The ovaries were aseptically removed and handled. Both ovaries from each animal were individually collected into 3 ml sterile dissection medium at 378C and immediately transferred to the laboratory. From each animal one-third of one ovary was fixed for histology [3.5% w/v paraformaldehyde (PFA, Merck KGaA, Darmstadt, Germany) in phosphate-buffered saline (PBS, Gibco-Invitrogen), 5 -6 h at room temperature] in order to evaluate the ovary health (results reported separately).
Ovaries were separated into pieces for further dissection and follicle puncture. COC's were recovered only from healthy antral follicles with a diameter not ,1000 mm. Degenerated and atretic follicles (dark, uneven granulosa and theca cells) were discarded at the outset. Only COCs with two or more compact cumulus cell layers completely surrounding the oocyte were selected for culture. From each ovary piece COC's selected for culture were immediately transferred into holding IVM medium without FSH and hCG (50 ml/well) under light mineral oil (Sigma-Aldrich) in 4 -well plates (NUNC, Thermo Fisher Scientific, Roskilde, Denmark). COC's were washed with three drops of medium and left in the incubator (controlled humidified atmosphere of 20% O 2 , 5% CO 2 , 38.38C) until the dissection of all ovary pieces was completed. COC's were randomly taken from all holding plates and equally divided between experimental groups with 5 -7 COC's per well of IVM medium with additives specific for the experimental group. COC's were then washed three times with 50 ml drops of this medium and finally transferred into maturation wells with the volume 25 ml. COC's were cultured in humidified atmosphere of 5% CO 2 in air at 38.38C for 29-30 h to induce maturation.
First microscopic observation was performed within 2 h after COCs were transferred into culture plates (before cumulus started to expand). For observation and taking photos an inverted Zeiss Axiovert 405 M microscope (Carl Zeiss MicroImaging GmbH, Goettingen, Germany) equipped with a heated chamber (378C) with continuous flow of 5% CO 2 in air and Canon A620 digital camera were used.
Sperm collection, preparation and IVF
For sperm collection and preparation a modification of the protocol developed by Kuederling et al. (2000) was used (Valle et al., 2008) . Three sperm donors were used for each experiment and the highest quality sample was chosen for fertilization, based on viability, motility and concentration. Oocytes from six out of seven experimental animals were fertilized with the sperm of the same donor, and in the single experiment, where another donor was used, fertilization rate did not differ from the mean.
Ejaculation was stimulated using a FertiCare personal vibrator (Multisept ApS, Rungsted, Denmark) fitted with a 2 cm×0.5 cm internal diameter glass tube serving as an artificial vagina. Sperm collection medium (Hepesbuffered Tyrodes-lactate, 100 ml, 378C) was immediately added to the ejaculate to inhibit the coagulation of seminal plasma.
In the laboratory ejaculates were gently mixed to break down any coagulum and, after volume evaluation, transferred into clean 1.5 ml tubes (Sarstedt, Nuembrecht, Germany). From each sample 5 ml was used for sperm concentration evaluation and another 5 ml for estimation of proportion of living and motile sperm. The volume of the remaining suspension was adjusted to 200 ml and it was carefully pipetted on the top of a two layer density gradient of Pure Sperm (NiDaCon International AB, Gothenburg, Sweden; 200 ml of 40% and 200 ml of 80% Pure Sperm in sperm collection medium). Closed tubes (1.5 ml) were then centrifuged for 18 min using soft mode at 300g, 378C. Then supernatant was carefully but quickly aspirated and the pellet transferred into a clean tube. Again 5 + 5 ml were taken for sperm quality and concentration evaluation and the remainder was carefully pipetted underneath 100 ml Tyrodes-lactate capacitation medium without calcium and left for 1.5 h in incubator for capacitation (378C, 5% CO 2 in air). After capacitation each sample was analysed for concentration, motility and speed of movement and the sample with the best characteristics was chosen for IVF. On average samples with concentration ca. 200 000 sperm/ml and 80% motility were acceptable.
One hour prior to IVF (28-29 h after IVM started) cumulus expansion of COCs was evaluated and they were transferred into 25 ml of IVFmedium after three times washing in 50 ml drops. The capacitated sperm sample was diluted with Tyrodes-lactate medium to the final concentration 20 000-30 000 sperm/ml and 2 ml of sperm was added to each 25 ml drop with COCs in IVF-medium. Thus, the total sperm number in each IVF drop was 40 -60 000 sperm/drop. Oocytes were cultured with sperm for 15 -16 h in humidified atmosphere in a gas mixture of 5%CO 2 , 5% O 2 and 90% N 2 at 38.38C: a reduced oxygen tension, compared with that used for IVM, was chosen for IVF and embryo culture, based on the evidence that, without protection of cumulus cells, oocytes and embryos can be damaged by high oxygen concentration and is supported by numerous studies in domestic as well as primate species (Thompson et al., 1990; Fischer and Bavister, 1993; Bavister, 2004; Leoni et al., 2007) .
Embryo culture
After 15 -16 h co-incubation with sperm [called embryo day (ED) 1], oocytes were gently freed from remaining cumulus cells and sperm using a capillary of 120 -140 mm diameter. After three times washing through FSH, hCG and epidermal growth factor in marmoset IVF embryo medium, oocytes were finally transferred into 25 ml culture drops. Thereafter oocytes were examined under inverted microscope and the maturation status and evidence of fertilization [2 polar bodies (PB) and the presence of pronuclei] were recorded. Oocytes with germinal vesicle (GV), GVBD (GV breakdown), 1 PB, fragmented PB or 2 PB without pronuclei were fixed for immunofluorescent staining. Oocytes with very dark and/or fragmented cytoplasm were counted as degenerated and discarded. Fertilized oocytes/zygotes were cultured in a gas mixture of 5%CO 2 , 5% O 2 and 90% N 2 and fixed on ED3. During embryo culture no further medium change was performed.
Immunocytochemical procedures
Immunostaining procedures were carried out according to Delimitreva et al. (2006) . Briefly, oocytes and embryos were fixed for 45 -60 min in 2% w/v PFA in PBS with 0.02% v/v Triton X-100 (Sigma-Aldrich) then washed twice in PBS with 0.3% w/v BSA and stored overnight (up to several days) at 48C in PBS + 0.3% BSA + 0.02% w/v Sodium azide (Sigma-Aldrich).
Microtubules were stained using monoclonal anti-a-tubulin mouse antibody (MP Biomedicals Germany GmbH, Eschwege, Germany 69 -125, 1:50) for 45 min and staining mixture of fluorescein isothiocyanate (1:100 FITC-goat anti-mouse immunoglobulin G F(ab ′ ) 2Frag. Affin. (Sigma-Aldrich) for 45 min in the dark. DNA was counterstained by 50 mg/ml Hoechst 33258 (Sigma-Aldrich) added to the same solution. Stained cells were then embedded in Mowiol w (Fluka, Sigma-Aldrich Chemie Gmbh, Munich, Germany) after impregnating medium with increasing concentrations of Mowiol stock. Object glasses were maintained in the dark at 48C overnight to allow the embedding medium to harden and next day they were observed using a digital camera mounted on a photo tube on a Zeiss fluorescent microscope (Axiophot) under oil using ×63 objective (a-tubulin FITC: emission 525 nm, excitation 490 nm, Hoechst: emission 480 nm, excitation 365 nm).
Experimental design
Four experimental groups for IVM which varied in gonadotrophin concentration and presence or absence of EGF at a fixed concentration were used: (A) 1 FSH +1 hCG; (B) 10 FSH +10 hCG; (C) 1 FSH +1 hCG + EGF; and (D) 10 FSH +10 hCG + EGF (where 1 and 10 are concentrations of gonadotrophins, IU/ml). Oocytes from each of the six animals were randomly distributed among all four experimental groups in order to minimize potential animal and oocyte differences. Evaluation of the results was performed daily using light microscopy of the living cells in their culture drops and subsequent analysis of fluorescently stained oocytes and embryos.
Cumulus expansion was evaluated after the end of maturation, before the COCs were transferred into fertilization medium, using four grades: 1, attached cumulus; 2, partially attached and expanded cumulus; 3, expanded cumulus with non-radial expansion; 4, cumulus with radial expansion (Fig. 1) . After co-incubation with sperm, the maturation stage of the oocyte was evaluated and classed as GV, GVBD metaphase I (MI), metaphase II (MII): developmental stage was evaluated as fertilized or not, and non-degenerated or degenerated based on presence of 1 or 2 PB's and pronuclei or presence of degenerative features. Zygotes and cleaving embryos were evaluated by pronuclei formation and extrusion of the second PB, and first cleavage to 2 cells plus subsequent cell divisions up to the third day (87-88 h after fertilization).
This short embryo culture period was chosen to allow the most effective evaluation of differences among the experimental groups in cell morphology and nuclear status during the first rounds of the cleavage before degeneration of any suboptimal embryos. Arrested stage of unfertilized oocytes was evaluated from fluorescent immunocytochemical images of microtubular cytoskeletal structures in the ooplasm. Final evaluation of embryo progression and blastomere quality was based on cell and nuclear fragmentation, chromatin dispersion and nuclear size difference in sibling blastomeres.
Statistical analysis
To evaluate the differences between experimental groups x 2 test was used. Differences with P , 0.05 were considered significant.
Results
Cumulus expansion
The pattern and degree of cumulus expansion of COC's were evaluated for each of the four experimental groups (Table I) . Only oocytes still connected to their cumulus cells were analysed (n ¼ 261). The highest proportion of COC's exhibiting radial cumulus expansion (21%, 14/67) occurred in Group A. Both addition of EGF and increase in gonadotrophins concentration to 10 IU produced an almost identical suppressive effect on radial cumulus expansion [reduction from 21 to 7% (4/55 and 5/70), respectively, P , 0.05] but there was no further inhibition of radial cumulus expansion with the addition of EGF to 10 IU gonadotrophins (Group D). Total cumulus expansion in Group A (the sum of COC's with radial, non-radial expansion and partially attached but expanded cumulus) was 58% (39/67), whereas Group B had only 41% (29/70) of COC's with expanded cumulus (the lowest expansion rate, P , 0.05). In contrast to the suppressive effect on radial cumulus expansion, the addition of EGF to 1 IU (Group C) did not change total cumulus expansion significantly (65%, 36/55), while in Group D the total expansion tended to increase [from 41% (29/70) to 57% (39/69)] This was an increase of 16% compared with 10 IU alone (Group B).
Oocyte maturation
Maturation status of the oocytes could only be determined after fertilization when the remaining still attached cumulus cells were mechanically removed. Before the co-incubation with sperm oocytes were thickly enclosed with cumulus cells, which hindered visualization of the oocyte and any presence of PB. Four cumulus-enclosed oocytes from Group B were lost during proceeding and thus were excluded from statistics. Maturation rate was calculated by pooling fertilized oocytes (2 PBs) together with those which had extruded 1 PB. The calculation of initiation of maturation includes the oocytes arrested at MI stage together with those which had completed maturation irrespective of fertilization status. The proportion of the oocytes, which had initiated maturation (MI) was similar among the groups (mean 82.5% of initial oocyte number; Fig. 2 ). The proportion of oocytes which completed maturation (MII) in Group A was 62% (47/76) (from starting number of oocytes) and 58% (38/66) in Group B, indicating that gonadotrophin concentration had no effect on completion of maturation. However, there was an apparent trend to suppression of MII progression in Group C, where only 48% (27/56) of oocytes matured. In contrast, EGF in the presence of 10 IU gonadotrophins (Group D) appeared to have no effect on progression to MII (60%, 42/70).
Degeneration
In total, 32 out of 268 oocytes degenerated in all four groups. The difference in degeneration rate was significant between Groups B (6%, 4/66) and C (18%, 10/56, P , 0.05) (Fig. 2) . Two other Groups A and D, had degeneration rates similar to each other (12%, 9/76 and 13%, 9/70) and did not differ significantly from the other two groups.
Fertilization
After the 29-30 h incubation in the four different maturation medium test groups, oocytes were put into a standard medium for fertilization. Although the differences in the number of fertilized oocytes from the number of matured were not statistically significant, there was a trend to the highest fertilization rate in Group A (55%, 26/47) and the Different subscripts represent significant differences (x 2 test) within one column, P , 0.05. COC, cumulus -oocyte complexes.
lowest (37%, 14/38) in Group B. Group C had 41% (11/27) and Group D-48% (20/42) fertilized oocytes.
Cleavage
Cleavage rate was calculated from the number of 2-cell embryos on ED1, either from the number of fertilized oocytes or from initial oocyte number in each group (Fig. 3) . Group A, which had shown a trend towards the highest fertilization rate, also produced the highest rate of first cleavage. 
Embryo progression on Day 2 and 3
The embryos were categorized by cell number; 2-3, 4-5 or 6 -8 on each day of development. By ED2 embryos were distributed between two categories: 2-3 cells and 4-5 cells (Table II) , whereas by ED3 some had reached 6-8 cells. Of the four treatment groups, Group A produced the largest number of embryos (19) with the second largest number (12) in Group D. On ED2 embryos were almost equally distributed between the two developmental stages (2 -3 and 4-5 cells) in all groups with the exception of Group B, where the only two embryos obtained had both progressed to 4-5 cell stage. On Day 3, in Group A, 21% (4/19) of the embryos had reached 6-8 cell stage, whereas no embryo has progressed to that stage in Group B. The proportion of 2-3 cell stage embryos decreased from 42% (8/19) to 32% (6/19) in Group A, and reduced by half (from 57%, 4/7 to 29%, 2/7) in Group B due to progression to 4-5 cells. In Group C, the only two embryos had further progressed to 6-8 cells and 33% (4/12) had progressed to 6-8 cell stage in Group D. Interestingly, in Group D, number of embryos remaining at 2-3 cell stage remained virtually unchanged (50%, 6/12 at the Day 3, compared with 58%, 7/12 at the Day 2), which means that only one had progressed to 4-5 cell embryo on Day 3, whereas contrastingly four-fifth of the 4-5 cell embryos from Day 2 had cleaved further by Day 3 in this group.
A tendency for improved developmental progression was generally observed in both groups with EGF. This led to similar actual number of the embryos of progressed stages at ED3 in three groups: 5% (4/76) of progressed embryos in Group A; 4% (2/56) in Group C and 6% (4/ 70) in Group D. Thus, at the stage of 6-8 cells rate of embryo production was the same in all groups except Group B.
Additionally, we have evaluated whether embryo production of each animal used for the experiment was condition-dependent. As was mentioned above, one animal at a time was used for the experiment and COC's from each animal were equally and randomly distributed between four groups. Although the pattern of embryo production remained similar for all animals, there was a difference in the number of animals producing embryos for different treatment groups. In Group B only two out of six animals (33%) produced embryos (3.5 per female). The addition of EGF to the high hormone concentration (Group D) resulted in embryo production from three of the six animals (50%, 4 embryos per female). Group A was associated with the highest proportion [4/6, (67%)] of animals producing cleaving embryos and the highest number of embryos per female (4.75) whereas the worst results were obtained in Group C: only one out of five animals (20%) produced cleaving embryos (2). In brackets numbers of fertilized or total oocytes in the group from which fertilization rate was calculated are given. In brackets total numbers of oocytes in each group are given (equal for each column in the group). *Differences are significant for degeneration rates between groups marked with the symbol (P , 0.05).
Evaluation of microtubular cytoskeleton of oocytes/zygotes which failed to cleave, and embryo quality
The potential involvement of cytoskeletal disturbances in oocytes which failed to cleave was investigated by evaluation of spindle shape in non-progressed MI, MII and fertilized but uncleaved oocytes. In total 53 oocytes from three animals were analysed in all four treatment groups. Lack of in vivo data prevents us from defining the true normal appearance of spindle but based on the differences among the oocytes produced in vitro in this study, we defined two groups: 'normal' (bipolar spindles with distinct poles, aligned tubulin fibres and chromosomes positioned on metaphase plate) or 'abnormal'. A wide range of spindle forms were contained within the abnormal group, and among the spindle defects observed were tiny, broad, multipolar spindles and disturbed spindles with unorganized microtubules. Examples of apparently normal and abnormal (disturbed spindle) are illustrated in Fig. 4 .
There was no significant difference in number of normal/abnormal oocytes between groups owing to the low numbers involved, but there was an apparent trend suggesting that Group A had the lowest number of normal-shaped spindles (13%, 2/15) among failed fertilized oocytes and Group C-the highest (31%, 4/13) (Table III) . In general, groups with EGF were apparently associated with more spindles of normal appearance at all stages (MI, MII, fertilized) than groups without EGF (29%, 6/21, in both EGF groups versus 16%, 5/32, in both groups without EGF).
However, in support of this data we also analysed the effect of EGF on the proportion of high-and low-quality embryos, based on the fluorescent observation of their nuclei size and presence/absence of multinucleation as shown in Fig. 5 . Embryos from Groups A and D were compared, with the observation that the proportion of 'good' embryos (with equal nucleus size and no multinucleation) was higher in Group D (71%, 5/7 versus 25%, 3/12; P , 0.05).
Discussion
This is a first study of the effects of EGF during IVM of unstimulated primates and also one of the few in any species which shows a negative effect of EGF. We are also the first to show differential effects depending on gonadotrophin concentration in IVM medium. Most previous studies have shown only positive or no effects of EGF on maturation and embryo development regardless of species (Harper and Brackett, 1993; Lonergan et al., 1996; Goud et al., 1998; Nyholt de Prada et al., 2009) , and only a few have reported negative effects (Gomez et al., 1993, Rota and Cabianca, 2004) .
Collectively, our study has shown that both high gonadotrophin levels without EGF and addition of EGF to cultures with low gonadotrophin levels suppress the oocyte radial expansion pattern. High gonadotrophins alone inhibit total expansion but EGF addition does not enhance this effect. In contrast, neither gonadotrophin dose nor EGF presence had an effect on MI or MII progression. At the same time EGF increases degeneration rate during culture in the IVM (11) 0 (0) 32 (6) 47 (9) 21 (4) 10 (B) 66** 38 14 7 2/6 57 (4) 43 (3) 0 (0) 29 (2) 71 (5) 0 (0) With EGF 1 (C) 56 27 11 2 1/5 0 (0) 100 (2) (7) 42 (5) 0 (0) 50 (6) 17 (2) 33 (4) *% of embryos achieved at each stage calculated from the total number of cleaved embryos in each group. **Initial oocyte number in the group is 70, but four were lost during proceeding and, thus, excluded from the statistics. MII, metaphase II. medium when combined with 1 IU FSH and hCG in comparison to 10 IU gonadotrophins alone. EGF does not affect the rate of fertilization, whereas high gonadotrophins tend to decrease it. Both increase of gonadotrophin concentration without EGF and the inclusion of EGF to the low gonadotrophins reduce the proportion of oocytes which achieve first cleavage. In contrast, once first cleavage occurs, EGF is associated with a faster rate of embryo cleavage than in its absence for a proportion of the embryos, and partially counteracts the negative effects of high gonadotrophins and increases the number of cleaving oocytes. However, the numbers of embryos involved is low and further confirmation of these results will be required.
Nowadays despite significant achievements in understanding some biochemical steps of oocyte maturation, molecular mechanisms that regulate meiosis resumption and PB extrusion remain obscure. In vitro animal models help to improve our understanding of the role of substances regulating oocyte maturation, such as gonadotrophins, steroids, growth factors, cyclic AMP (cAMP), calcium and cell-cycle proteins. cAMP plays a central role in regulation of the maturation process and has a dual action: whereas high levels of cAMP within the oocyte support meiotic arrest, a decrease in oocyte intracellular level of cAMP together with its rise in the somatic cells of the follicle is necessary for resumption of meiosis (Dekel et 18 (3) 82 (14) 17
With EGF 1 (C) 31 (4) 69 (9) 13 10 (D)
25 (2) 75 (6) 8 Oocytes at MI and MII stage which were fertilized but failed to form pronuclei were analysed for cell spindle morphology. Figure 5 Light (A-C) and fluorescence (D-F) photos of marmoset monkey embryos of different qualities.
Good quality embryo with equal size and distribution of nuclei (A, D); poor quality embryo with one multinucleated cell (B, E) and poor quality aneuploid embryo, characterized by unequal nuclei and cell size (C, F). Upper scale bar is for light photos (100 mm) and lower scale bar is for fluorescence (100 mm). Diameter of stained embryos is significantly bigger than diameter of embryos in culture owing to flattening caused by embedding.
et al., 2008). Further, mediated by cAMP, the process of maturation is controlled by two protein kinases: mitogen-activated protein kinase (p42 MAPK) and maturation-promoting factor (MPF) and involves activation of the proto-oncogene protein Mos: a cascade, involving these three elements (Mos/MAPK cascade and activation of MPF) is considered to lead to GVBD (Motola et al., 2008) . Moreover, the Mos/MAPK cascade was shown to be involved in the control of microtubule and chromatin organization during meiosis (Verlhac et al., 1996) . EGF effects, the same as FSH and LH, utilize MAPK activation and furthermore, EGF receptors (EGFR) are present on granulosa cells, as are those for gonadotrophins (Chabot et al., 1986) . It was also shown for primates and human, that EGF has receptors within the oocyte, as well as cumulus cells (Maruo et al., 1993; Nyholt de Prada et al., 2009) . But while both FSH and hCG act via cumulus cells, mainly through the cAMP signalling pathway (transcriptional mechanism), EGF action seems to be non-transcriptional and may not require the presence of cumulus (Das et al., 1991; Farin et al., 2007) . There is reciprocal regulation of receptor expression between gonadotrophins and EGF. Whereas both gonadotrophins up-regulate EGFR, and FSH and LH receptor (FSHR and LHR, respectively) expression, EGF has an inhibitory effect on the receptors for both gonadotrophins (Fujinaga et al., 1994; Choi et al., 2009; Findlay and Drummond, 1999; Piquette et al., 1991; Knecht and Catt, 1983) . This may partially explain our observation of a protective effect of EGF added to a high gonadotrophin group, where inhibition of FSHR and LHR expression by EGF may lead to a diminished gonadotrophin signalling, thus overcoming, their probable overdose effect. In the presence of low gonadotrophins FSHRs and LHRs may be down-regulated by EGF to a non-functional level.
We showed that rates of initiation and completion of maturation were not affected by either EGF or gonadotrophin concentration. EGF and gonadotrophin concentration exhibited no apparent effect on 'nuclear' maturation, and thus, all the subsequent differences in oocyte and embryo development derive from their effect on 'cytoplasmic' maturation of the oocyte. Our results for maturation are, in part, similar to those of Gomez et al. (1993) and Goud et al. (1998) for human oocytes, Nyholt de Prada et al. (2009) for rhesus oocytes, Harper and Brackett (1993) for bovine, Abeydeera et al. (1998) for pig, Bolamba et al. (2006) for dog and Merriman et al. (1998) for mice: these authors all found no effect of adding EGF to IVM medium on MI and MII progression of oocytes within COC's. However, there is also a range of studies on different species, which all demonstrated a positive effect of EGF on oocyte maturation rates (Lonergan et al., 1996; for bovine, Farin et al. (2007) and Merlo et al. (2005) for domestic cat and De La Fuente et al. (1999) for mouse COCs). Some authors also show EGF and FSH to be additive in their positive effect on maturation of non-stimulated gilt (Singh et al., 1993) and cat (Farin et al., 2007) oocytes. So it appears that the action of EGF is likely to be affected by other variables, such as in vitro environment.
In the present study, we matured oocytes from non-stimulated marmoset ovaries in a 'rich medium' containing FBS, FSH, hCG and E 2 , because these conditions had produced the 'best' results so far for marmoset oocyte maturation in our hands. Our analyses of the studies with other species have suggested to us that EGF (with few exceptions) shows the greatest effect in the absence of other stimulating factors either defined (gonadotrophins, E 2 , other growth factors) or undefined (as in FBS) (Das et al., 1991; Singh et al., 1993; Harper and Brackett, 1993; Lonergan et al., 1996; De La Fuente et al., 1999; Li et al., 2002; Rota and Cabianca, 2004) . Additionally, we would like to mention that FBS used in the experiment as a component of basic media for IVM, IVF and embryo development, might also be expected to contain EGF, but we were unable to find published values for EGF for any bovine serum. Thus, we have considered the basal EGF level in serum used here as background, and kept this background constant by carrying out all experiments with one batch of FBS. On the basis of this, our experimental conditions would have been expected to suppress a positive effect of EGF on oocyte function and embryo development (Goud et al., 1998; Harper and Brackett, 1993; Singh et al., 1993; Merriman et al., 1998) , but would not have been predicted to induce the negative effect which we observed with the lower dose of gonadotrophins. To fully understand the influence of various factors in IVM of oocytes, the concentration of EGF in sera should be determined.
However, it cannot be ignored that the concentration of EGF used in our study might be an overdose for some of the antral follicles which we have used. What may constitute an optimal dose of EGF will depend upon the conditions, on the follicular origin of the oocytes, as well as on the species. For example, in pig 10 ng/ml EGF had the highest positive effect, whereas with 40 ng/ml no effect was observed (Abeydeera et al., 1998) . In cat the same pattern was observed for 25 -50 ng/ml EGF (Merlo et al., 2005) . For cattle, Ali and Sirard (2002) reported the dose of 30 ng/ml to be optimal, whereas Lonergan et al. (1996) showed no difference in positive effect of EGF from 1 to 100 ng/ml. Gomez et al. (1993) showed no effect of 1 ng/ml EGF on maturation rate of human oocytes, whereas 10 ng/ml EGF tended to be inhibitory, similar to the findings in the present study. Finally, 100 ng/ml EGF showed no effect on rhesus oocyte maturation and cleavage (Nyholt de Prada et al., 2009) ; however, as they used only this one dose, further trials are needed to determine whether another concentration would have produced a different result.
In support of the overdose hypothesis, we observed that in the presence of EGF in IVM medium, with low gonadotrophins the degeneration rate was significantly higher than in the high gonadotrophin group without EGF. These results, which are based on appearance of unstained oocytes, contrast with those of Illera et al. (1998) for pig and Merlo et al. (2005) for domestic cat. Further, our preliminary results (data not included) with fluorescent microscopy have suggested that more oocytes with apoptotic-like nuclei (fragmented and/or collapsed) are present in the groups containing EGF. Interestingly, Murray et al. (1993) after in vivo treatment of sheep with EGF, made an assumption that atresia may occur in antral follicles which are exposed to EGF too early in their development. This result may partially explain our findings, because most of the marmoset oocytes were from small and medium sized non-dominant antral follicles.
Further, the negative effect of EGF in the low gonadotrophins group (Group C) in the present study was indicated most strongly by the decrease in embryo numbers. This differs from results for human and rhesus (Goud et al., 1998; Nyholt de Prada et al., 2009) after in vivo stimulation which showed no effect of EGF on embryo production rate but does correspond with our findings for EGF together with high gonadotrophins (Group D). Interestingly, despite the differing effects of EGF on the rate of first cleavage, depending on gonadotrophin concentration (either inhibitive with low FSH/hCG or neutral with high gonadotrophins), we observed a tendency towards 'faster' embryo progression in the EGF containing groups. This result is in agreement with the bovine study from Lonergan et al. (1996) and we could assume that EGF inhibited the development of low-quality embryos and increased the speed of the development of higher quality ones. As a result, all groups, except for 10 IU without EGF (Group B), produced an equal rate of 6-8 cell embryos by Day 3. Faster embryo cleavage by itself is a marker of better embryo quality correlating with better morphological quality, lower aneuploidy rate and higher blastocyst formation rates in comparison to slow cleaving embryos (Lundin et al., 2001; Luna et al., 2008) . Here, we should mention that a negative effect of high gonadotrophin concentration on embryo progression together with low first cleavage rate suggests a gonadotrophin overdose under current conditions but, interestingly, inhibition of embryo progression can be partially overcome by EGF.
The same inhibitory effect of high gonadotrophins and partially protective action of EGF was observed for cumulus expansion. High gonadotrophins (Group B) decreased significantly both radial and total cumulus cells expansion when used alone, compared with low gonadotrophins (Group A). However, expansion rates did not differ significantly from Group A when high gonadotrophins were combined with EGF (Group D). In contrast, EGF addition to low gonadotrophins (Group C) markedly reduced radial expansion, but did not change total expansion rate (including all expansion grades); an issue which needs further investigation. A similar trend was published for canine, and was related to the presence of E 2 in IVM medium (Bolamba et al., 2006) . It was shown, that in the presence of E 2 EGF eliminated high-grade cumulus expansion, whereas a combination of FSH + LH+ E 2 + EGF resulted in the highest rate of the high-grade expansion. This is a complex issue involving multiple pathways which requires further investigation.
Evaluation of some of the oocytes which failed to complete maturation or fertilization in our study has shown an apparent trend towards association of EGF with an increased proportion of oocytes with well-organized spindle shape, although with such low numbers few firm conclusions can be made. This could suggest that the negative effect of EGF on cleavage rate in a low gonadotrophin group is not associated with the spindle organization of the oocyte. However, this finding is also consistent with results from mouse oocytes where EGF was shown to improve cytoskeletal organization (Rossi et al., 2006) , an effect which appears to be potentiated by the presence of gonadotrophins in porcine (Ueno et al., 2005) . Since when working with any monkey species the limitations of obtaining material are severe, a major effort is required to obtain large enough numbers of oocytes adequate for statistical analysis. For this reason priority was given to the fertilization experiment and no oocytes were reserved for spindle evaluation prior to fertilization. Previous work from our group (Delimitreva et al., 2006) has shown that in vitro matured marmoset oocytes have a high incidence of abnormal spindle or unaligned chromosomes.
Additionally some of the embryos were evaluated by fluorescence microscopy using nuclear size as a criterion for embryo quality and marker of aneuploidy (according to Agerholm et al., 2008) . Embryos from Groups A and D (the two best groups) were compared, with the observation that the proportion of 'good' embryos (with equal nucleus size and no multinucleation) was higher in the group with EGF (D) in spite of the lower total number of embryos. This result supports the supposition that EGF may have a positive effect on spindle organization for a proportion of the oocytes. But for oocytes of suboptimal quality (or those from early stage antral follicles) EGF may be damaging. This suggestion is also in agreement with the results of Delimitreva et al. (2006) which showed that spindle abnormality and aneuploidy is a major problem for marmoset oocytes matured in vitro with high dose gonadotrophins without EGF, and that most spindle abnormalities occurred in the small follicle group.
In the present study, we have focused on the early stages of embryo development and the differences in embryo quality observed already at the stages up to 8 cells. The authors considered that culture of early stage embryos was the most efficient strategy at this stage of our knowledge allowing an evaluation of speed of embryo division and nuclear size as indicators of normal cleavage. Leaving embryos in culture until development ceased or until blastocyst stage was reached would have resulted in loss of diagnostic accuracy for those which arrested. This is particularly important because of the innate difficulties in obtaining adequate amounts of material from a primate species, and our incomplete basic knowledge of any primate species embryo development. Further, since ovarian changes associated with the monkeys being overweight were found in the material used in this study (Bernhard, personal communication) , the possibility that the associated physiological changes might influence the quality of some oocytes was taken into account and provided a further justification for concentrating on early embryo development.
In conclusion, it is clear from these results that effectiveness of IVM/ IVF depends on the maintenance of the 'correct' balance of the various factors involved in oocyte maturation and embryo development. The appropriate balance may differ depending on the developmental stage of the follicle from which the oocyte is harvested and the health state of the oocyte -follicle complex. Thus, it would be particularly important to characterize the in vitro requirements of marmoset oocytes originating from small antral follicles compared with oocytes from pre-ovulatory follicles and to evaluate the responses of oocytes of 'healthy' ovaries. We also suggest that additional studies of intra-and intercellular mechanisms of EGF action in combination with other local growth factors, and in differing hormonal milieu, are necessary. To find an optimal concentration of EGF specific for marmoset IVM, a dose-response study must be performed under optimized conditions. Furthermore, in order to more closely mimic the normal sequence of events in vivo, a 2-phase IVM system may be advantageous (as discussed in Gilchrist and Thompson, 2007) to allow oocytes from small antral follicles to complete their 'functional' maturation before meiotic maturation is induced. Without this evidence, basic research on embryo production obtained from oocytes which mature in vitro is unlikely to achieve an adequate level of success.
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